Herbal Formula Science (대한한의학방제학회지)

The Korean Medicine Society for the Herbal Formula Study (대한한의학방제학회)
권호 표지
DOI QR코드

DOI QR Code

Efficacy and Safety of Combination Treatment of Traditional Korean Medicine after Gastric Cancer Surgery: A Systematic Review and Meta-analysis Protocol

위암 수술 후 항암치료를 병행한 한의치료의 유효성 및 안전성: 체계적 문헌고찰 및 메타분석 프로토콜

  • Jong-hee Kim (College of Korean Medicine, Daejeon University) ;
  • Eunbin Kwag (College of Korean Medicine, Daejeon University) ;
  • So-jung Park (Department of Korean medicine, school of Korean medicine, Pusan National University) ;
  • Donghyun Kim (College of Korean Medicine, Daejeon University) ;
  • Soodam Kim (KM Science Research Division, Korea Institute of Oriental Medicine) ;
  • Jihye Park (East West Cancer Center, Seoul Korean Medicine Hospital, Daejeon University) ;
  • Hwa-seung Yoo (College of Korean Medicine, Daejeon University)
  • 김종희 (대전대학교 대전한방병원 임상시험센터) ;
  • 곽은빈 (대전대학교 대전한방병원 임상시험센터) ;
  • 박소정 (부산대학교 한방병원 한의약 임상연구센터) ;
  • 김동현 (대전대학교 대전한방병원 임상시험센터) ;
  • 김수담 (한국한의학연구원 한의과학연구부) ;
  • 박지혜 (대전대학교 서울한방병원 동서암센터) ;
  • 유화승 (대전대학교 대전한방병원 임상시험센터)
  • Received : 2023.08.11
  • Accepted : 2023.11.01
  • Published : 2023.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : Gastric cancer is a malignant tumor of the digestive tract that not only has a high mortality rate, but also affects quality of life. In Traditional Korean Medicine, acupuncture and herbal medicines can increase the survival rate for Gastric cancer and improve the quality of life. Traditional Korean Medicine treatment played an important role when used alone or in combination with chemotherapy. However, there is still insufficient evidence to support the efficacy and safety of Traditional Korean Medicine in patients undergoing chemotherapy after surgery. Therefore, the purpose of this study is to systematically evaluate the effect of oriental medicine treatment on patients as a complementary therapy for Gastric cancer. Methods : 2 researchers will search using EMBASE, Pubmed, CNKI, Cochrane Library, CiNii, KMBASE, KISS, OASIS, RISS, ScienceON. The search period of the database is from inception until June 2022. This study will include a randomized controlled trial of GC for acupuncture and herbal treatment. Primary outcomes include anti-cancer effects. Secondary outcomes evaluate survival rates and improvements in quality of life. The data uses Review Manager Software 5.4. Results : This study will provide a systematic evaluation by synthesizing the anti-cancer effect, survival rate and quality of life of Gastric cancer when Traditional Korean Medicine is combined with chemotherapy. Conclusion : The conclusion of this study will provide a basis for determining whether Traditional Korean Medicine treatment for Gastric cancer treatment is an effective and safe treatment method in clinical practice.

Keywords

Acknowledgement

This research was supported by the Daejeon University Research Grants (2022).

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249.  https://doi.org/10.3322/caac.21660
  2. National Center Information Cancer. Gastric cancer statistics. Republic of Korea: Ministry of Health and Welfare [serial online] 2018 [cited 2022 Aug 10]; Available from: URL: https://www.cancer.go.kr. 
  3. Sbaraglia M, Businello G, Bellan E, Fassan M, Dei Tos AP. Mesenchymal tumours of the gastrointestinal tract. Pathologica. 2021;113(3):230-251.  https://doi.org/10.32074/1591-951X-309
  4. Pan X, Tao H, Nie M, Liu Y, Huang P, Liu S, et al. A clinical study of traditional Chinese medicine prolonging the survival of advanced gastric cancer patients by regulating the immunosuppressive cell population: A study protocol for a multicenter, randomized controlled trail. Medicine (Baltimore). 2020;99(16):e19757. 
  5. Gao Q, Li H, Zou Y, Hou B, Liu L. Effectiveness of a comprehensive post-operative health education program in improving quality of life after gastric cancer surgery. Ann Palliat Med. 2020;9(3):921-926.  https://doi.org/10.21037/apm.2020.04.14
  6. Carrillo GM, Santamaria NP. Life after a gastrectomy: Experience of patients with gastric cancer. Vivir despues de una gastrectomia: experiencia de pacientes con cancer gastrico. Enferm Clin (Engl Ed). 2019;29(1):27-33.  https://doi.org/10.1016/j.enfcli.2018.06.006
  7. Zhang Y, Lou Y, Wang J, Yu C, Shen W. Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment. Front Immunol. 2021;11:609705. 
  8. Hung KF, Hsu CP, Chiang JH, Lin HJ, Kuo YT, Sun MF, Yen HR. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort study. J Ethnopharmacol. 2017;199:168-174.  https://doi.org/10.1016/j.jep.2017.02.004
  9. National Health Commission Of The People's Republic Of China. Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version). Chin J Cancer Res. 2019;31(5):707-737.  https://doi.org/10.21147/j.issn.1000-9604.2019.05.01
  10. Zhou J, Fang L, Wu WY, et al. The effect of acupuncture on chemotherapy-associated gastrointestinal symptoms in gastric cancer. Curr Oncol. 2017;24(1):e1-e5.  https://doi.org/10.3747/co.24.3296
  11. Miao X, Wu H, Liu Y, Zhang S, Li C, Hao J. Treatment Alternative and High Safety Profile of Acupuncture Plus Chemotherapy for Advanced Gastric Cancer. Evid Based Complement Alternat Med. 2022;2022:8701779. 
  12. Huo J, Qin F, Cai X, Ju J, Hu C, Wang Z, et al. Chinese medicine formula "Weikang Keli" induces autophagic cell death on human gastric cancer cell line SGC-7901. Phytomedicine. 2013;20(2):159-165.  https://doi.org/10.1016/j.phymed.2012.10.001
  13. Gao Z, Deng G, Li Y, Huang H, Sun X, Shi H, et al. Actinidia chinensis Planch prevents proliferation and migration of gastric cancer associated with apoptosis, ferroptosis activation and mesenchymal phenotype suppression. Biomed Pharmacother. 2020;126:110092. 
  14. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. 
  15. Gotschall T. EndNote 20 desktop version. J Med Libr Assoc. 2021;109(3):520-522.  https://doi.org/10.5195/jmla.2021.1260
  16. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. 
  17. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380-382.  https://doi.org/10.1016/j.jclinepi.2010.09.011
  18. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26-38.  https://doi.org/10.5114/pg.2018.80001
  19. Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264-279.  https://doi.org/10.3322/caac.21657
  20. Stewart C, Chao J, Chen YJ, et al. Multimodality management of locally advanced gastric cancer-the timing and extent of surgery. Transl Gastroenterol Hepatol. 2019;4:42. 
  21. Crona DJ, Faso A, Nishijima TF, McGraw KA, Galsky MD, Milowsky MI. A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity. Oncologist. 2017;22(5):609-619.  https://doi.org/10.1634/theoncologist.2016-0319
  22. Shinde A, Novak J, Amini A, Chen YJ. The evolving role of radiation therapy for resectable and unresectable gastric cancer. Transl Gastroenterol Hepatol. 2019;4:64. 
  23. LeeCW, ParkMI, ParkSJ, et al. FOLFOX-4 Combination Chemotherapy as a First-line Treatment in Patients with Advanced Gastric Cancer. Korean J Med. 2012;82 (1): 37-44.  https://doi.org/10.3904/kjm.2012.82.1.37
  24. Park SR, Kang YK. Perioperative treatments for resectable gastric cancer. J Korean Med Assoc. 2015 Mar;58(3):201-208.  https://doi.org/10.5124/jkma.2015.58.3.201
  25. Johnston FM, Beckman M. Updates on Management of Gastric Cancer. Curr Oncol Rep. 2019;21(8):67. 
  26. Xu Y, Zhao AG, Li ZY, Zhao G, Cai Y, Zhu XH, et al. Survival benefit of traditional Chinese herbal medicine (a herbal formula for invigorating spleen) for patients with advanced gastric cancer. Integr Cancer Ther. 2013;12(5):414-422.  https://doi.org/10.1177/1534735412450512
  27. Wang M, Tian Z, Zhu Y, Ding J, Li C, Zhou Y, et al. Sichong formula inhibits the proliferation and migration of human gastric cancer cells. Onco Targets Ther. 2019;12:5741-5750.  https://doi.org/10.2147/OTT.S199605
  28. Shih WT, Yang PR, Shen YC, Yang YH, Wu CY. Traditional Chinese Medicine Enhances Survival in Patients with Gastric Cancer after Surgery and Adjuvant Chemotherapy in Taiwan: A Nationwide Matched Cohort Study. Evid Based Complement Alternat Med. 2021;2021:7584631. 
  29. Takahashi T, Endo S, Nakajima K, Souma Y, Nishida T. Effect of rikkunshito, a chinese herbal medicine, on stasis in patients after pylorus-preserving gastrectomy. World J Surg. 2009;33(2):296-302.  https://doi.org/10.1007/s00268-008-9854-8
  30. Yu Q, Chen Z, Tang X. Study on early application of Chinese medicinal herbs after total gastrectomy. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999;19(10):592-594. 
  31. Zhang Z, Li B, Huang J, Huang S, He D, Peng W, et al. A Network Pharmacology Analysis of the Active Components of the Traditional Chinese Medicine Zuojinwan in Patients with Gastric Cancer. Med Sci Monit. 2020;26:e923327. 
  32. Lee YK, Bae K, Yoo HS, Cho SH. Benefit of Adjuvant Traditional Herbal Medicine With Chemotherapy for Resectable Gastric Cancer. Integr Cancer Ther. 2018;17(3):619-627. https://doi.org/10.1177/1534735417753542